Ethical issues in a TwiCs study in early PsA
Main Authors: | Coates, L, Tillett, W, Torgerson, D, McHugh, N, Taylor, P |
---|---|
Format: | Conference item |
Published: |
BioMed Central
2017
|
Similar Items
-
Assessment of the many faces of PsA: single and composite measures in PsA clinical trials
by: McGagh, D, et al.
Published: (2020) -
Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PsA-1 and SELECT-PsA-2 trials assessed according to modified PsARC
by: Coates, LC, et al.
Published: (2021) -
Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PSA-1 and SELECT-PsA-2 trials assessed according to modified PsARC
by: Coates, LC, et al.
Published: (2022) -
Treat-to-target in PsA: methods and necessity
by: Dures, E, et al.
Published: (2020) -
Value of RAPID3 in patients with PsA: results from the TICOPA and LOPAS II databases
by: Coates, L, et al.
Published: (2017)